Chenghe Wang

729 total citations
39 papers, 495 citations indexed

About

Chenghe Wang is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Chenghe Wang has authored 39 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 20 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Chenghe Wang's work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (9 papers). Chenghe Wang is often cited by papers focused on MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (9 papers). Chenghe Wang collaborates with scholars based in China and United States. Chenghe Wang's co-authors include Yu Zhu, Zhangqun Ye, Wen Jiang, Zhong Chen, Qingsong Zhang, Jia Hu, Dandan Zhu, Chuanchang Li, Zhong Chen and Kai Cui and has published in prestigious journals such as Biochemical and Biophysical Research Communications, BioMed Research International and Cell Death and Disease.

In The Last Decade

Chenghe Wang

35 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenghe Wang China	12	332	282	93	80	76	39	495
Xiaohong Du China	12	237 0.7×	166 0.6×	48 0.5×	49 0.6×	58 0.8×	19	374
Jinsong Wang China	13	387 1.2×	239 0.8×	37 0.4×	93 1.2×	120 1.6×	29	550
Xiaoxiao Yao China	8	316 1.0×	295 1.0×	49 0.5×	66 0.8×	81 1.1×	11	471
Ju Guo China	13	286 0.9×	190 0.7×	67 0.7×	161 2.0×	74 1.0×	41	458
Xiaojie Bian China	12	340 1.0×	270 1.0×	54 0.6×	104 1.3×	183 2.4×	24	573
Lujia Zou China	10	182 0.5×	127 0.5×	108 1.2×	92 1.1×	43 0.6×	26	353
Haiyan Si China	12	292 0.9×	270 1.0×	85 0.9×	90 1.1×	173 2.3×	36	539
Yuansheng Duan China	13	231 0.7×	123 0.4×	64 0.7×	46 0.6×	109 1.4×	33	402
Niraj Maskey China	10	231 0.7×	187 0.7×	104 1.1×	42 0.5×	108 1.4×	17	413
Shaoqing Ju China	16	372 1.1×	402 1.4×	49 0.5×	79 1.0×	91 1.2×	29	555

Countries citing papers authored by Chenghe Wang

Since Specialization

Citations

This map shows the geographic impact of Chenghe Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghe Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghe Wang more than expected).

Fields of papers citing papers by Chenghe Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenghe Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghe Wang. The network helps show where Chenghe Wang may publish in the future.

Co-authorship network of co-authors of Chenghe Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chenghe Wang. A scholar is included among the top collaborators of Chenghe Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenghe Wang. Chenghe Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Zhiyang, et al.. (2025). Comprehensive investigation identifies CPSF3 as a novel prognostic and oncogenic biomarker in bladder cancer. Discover Oncology. 16(1). 1847–1847.

Zhuo, Ran, Fang Chen, Jun Dai, et al.. (2024). HIF1A transcriptional regulation of COX4I2 impacts angiogenesis in pheochromocytoma. Biochemical and Biophysical Research Communications. 704. 149638–149638. 2 indexed citations

Xie, Jing, et al.. (2024). Case report: Rare case of a preoperatively diagnosed spermatic cord paraganglioma and literature review. Frontiers in Oncology. 14. 1373727–1373727.

He, Wei, et al.. (2023). Forkhead box F1 functions as a novel prognostic biomarker and induces caspase‑dependent apoptosis in bladder cancer. Oncology Reports. 50(3). 1 indexed citations

Wang, Chenghe, et al.. (2023). Identification and validation of a novel prognostic model based on platinum resistance-related genes in bladder cancer. International braz j urol. 49(1). 61–88. 3 indexed citations

Wang, Chenghe, et al.. (2021). High TNFSF13B expression as a predictor of poor prognosis in adrenocortical carcinoma. Translational Andrology and Urology. 10(8). 3275–3285. 4 indexed citations

Dai, Jun, et al.. (2021). Case Report: Rare Case of Synchronous Neck Metastasis From Metachronous Bilateral Renal Cell Carcinoma. Frontiers in Oncology. 11. 677714–677714.

Jiang, Wen, Dandan Zhu, Chenghe Wang, & Yu Zhu. (2020). Tumor suppressing effects of tristetraprolin and its small double‐stranded RNAs in bladder cancer. Cancer Medicine. 10(1). 269–285. 4 indexed citations

Wang, Chenghe, et al.. (2020). A Low Noise Precision Operational Amplifier. 1–3.

10.

Zhuo, Ran, Jun Dai, Fang Chen, et al.. (2020). Surgical outcomes of a randomized controlled trial compared robotic versus laparoscopic adrenalectomy for pheochromocytoma. European Journal of Surgical Oncology. 46(10). 1843–1847. 32 indexed citations

11.

Wang, Xiaojing, Xiaoxia Li, Meng Li, et al.. (2019). Apogossypolone acts as a metastasis inhibitor via up-regulation of E-cadherin dependent on the GSK-3/AKT complex.. Europe PMC (PubMed Central). 11(1). 218–232. 5 indexed citations

12.

Jiang, Wen, Qing Guo, Chenghe Wang, & Yu Zhu. (2019). A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. Cancer Cell International. 19(1). 208–208. 29 indexed citations

13.

Zhang, Qingsong, Shuo Miao, Chuanchang Li, et al.. (2018). MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21. Cell Death and Disease. 9(10). 960–960. 53 indexed citations

14.

Wang, Chenghe, et al.. (2018). A Novel Class AB CMOS Operational Amplifier. DEStech Transactions on Computer Science and Engineering. 1 indexed citations

15.

Li, Meng, Feifei Xu, Yunze Xu, et al.. (2017). Enhanced wild-type p53 expression by small activating RNA dsP53-285 induces cell cycle arrest and apoptosis in pheochromocytoma cell line PC12. Oncology Reports. 38(5). 3160–3166. 7 indexed citations

16.

Li, Xiaoxia, Yunze Xu, Meng Li, et al.. (2017). Apogossypolone (ApoG2) induces ROS-dependent apoptosis and reduces invasiveness of PC12 cells in vitro and in vivo.. PubMed. 9(9). 3990–4002. 6 indexed citations

17.

Wang, Chenghe, Yu Xiao, Huanlei Wu, et al.. (2016). miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression. Oncology Reports. 37(1). 241–248. 50 indexed citations

18.

Chen, Zhong, Qiangqiang Ge, Chenghe Wang, et al.. (2016). Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells. OncoTargets and Therapy. 9. 231–231. 8 indexed citations

19.

Wang, Chenghe, Qiangqiang Ge, Qingsong Zhang, et al.. (2016). Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis. Journal of Experimental & Clinical Cancer Research. 35(1). 29 indexed citations

20.

Wang, Chenghe, Qiangqiang Ge, Zhong Chen, et al.. (2015). Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 CIP1/WAF1 expression. Tumor Biology. 37(5). 6589–6598. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact